PubHawk
November 2010 PMID 21045096

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.

Joseph F Quinn, Rema Raman, Ronald G Thomas, Karin Yurko-Mauro, Edward B Nelson, Christopher Van Dyck, James E Galvin, Jennifer Emond, Clifford R Jack, Michael Weiner, Lynne Shinto, Paul S Aisen

Download social card

Mentions

30
Peak: 1 in Oct 2022
across 4 sources since Oct 2022

Extended reach

36,124
potential audience

Total likes

574

Video views

36,110

Mentions per month

Oct 2022 – Nov 2025

Where it's discussed

  • News15 articles
  • Blogs12 articles
  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

Many discussions mention the article's conclusion that DHA does not significantly slow cognitive decline in Alzheimer’s patients, reflected in phrases like 'no real benefits' or 'questioning the effectiveness.' The tone varies from skeptical to neutral, and the comments tend to briefly acknowledge or critique the study, indicating a moderate level of engagement and impact.

AgreementNeither agree nor disagree

Responses show mixed opinions, with some supporting the findings and others questioning or dismissing them.

InterestNeutral interest

Discussions appear neutral, with no strong enthusiasm or disinterest expressed.

EngagementNeutral engagement

Comments seem to include some brief observations and critiques but lack deep analysis or extensive discussion.

ImpactNeutral impact

The overall tone indicates the article's influence on ongoing conversations is moderate, with some considering it noteworthy but not transformative.

Abstract in brief

  • The study investigated whether DHA, an important fatty acid in the brain, can slow cognitive decline in people with Alzheimer's disease by conducting a randomized, double-blind, placebo-controlled trial over 18 months.
  • Participants were given either DHA supplements or a placebo, and results showed no significant difference in cognitive decline, brain atrophy, or functional deterioration between the two groups.
  • Overall, the findings suggest that DHA supplementation does not have a beneficial effect on slowing cognitive or functional decline in individuals with mild to moderate Alzheimer's disease.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Iasonas Theodoropoulos
@BodybuildingSc5 · X

Citations 1. https://t.co/WiTJ79ovlb 2. https://t.co/Z3VGcgAK2I 3. https://t.co/k9AKngWyYz 4. https://t.co/LiJGH2gX3I 5. https://t.co/P8ljjAQiUn 6. https://t.co/2iuXX6ZMpI 7. https://t.co/1mtfRx4pg4 8. https://t.co/kMA0O6Uw2B 9. https://t.co/OBbc01QIAP 10. https://t.co/8fUqzso58m

Mar 11, 2023 · 15 followers View post →

All mentions

Iasonas Theodoropoulos
@BodybuildingSc5 · X

Citations 1. https://t.co/WiTJ79ovlb 2. https://t.co/Z3VGcgAK2I 3. https://t.co/k9AKngWyYz 4. https://t.co/LiJGH2gX3I 5. https://t.co/P8ljjAQiUn 6. https://t.co/2iuXX6ZMpI 7. https://t.co/1mtfRx4pg4 8. https://t.co/kMA0O6Uw2B 9. https://t.co/OBbc01QIAP 10. https://t.co/8fUqzso58m

Mar 11, 2023 · 15 followers View post →